Jacques PFISTER
MBA
-
Previously President of "CCI Marseille Provence"
CCI Marseille Provence
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
Marseille Immunopole is one spearheads of the Aix-Marseille-Provence Metropolis excellence, in research as in the economy field.
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
CCI Marseille Provence, already at the initiative of the Eurobiomed cluster, accompanies this ambitious metropolitan project in its entrepreneurial and international dimensions. Alongside with its institutional partners, it facilitates the development of companies and contributes to the development of this project.
Health is a major economical sector of Aix-Marseille-Provence Metropolis. Combining a high-level public and private healthcare offer with high research potential, it constitutes an expanding strategic sector for CCI Marseille Provence, which gave rise to numerous ambitious and innovative entrepreneurial initiatives.
Combined successes of Éric Vivier, a world-renowned researcher, Hervé Brailly and Vincent Fert, entrepreneurs who have both developed their companies in a remarkable way, illustrate perfectly the dynamism and the innovative capacity of our territory in this essential area.
Have a look on our testimonies
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients
Emmanuelle CHARAFE-JAUFFRET
AMU, IPC, CRCM
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
Nicolas SCHLEINITZ
AP-HM, AMU
Education is also one of the strategic components of the Marseille Immunopole project
Françoise DIGNAT-GEORGE
AMU, AP-HM, VRCM
MI should enable us to accelerate discovery, enhance our treatment options and offer more innovative options to our patients through current clinical trials and those of the future.
Fabrice BARLESI
AP-HM, AMU
your commitment to MI